Structured evidence table for Artichoke Leaf Cholesterol Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Artichoke Leaf Cholesterol Randomized Trial | Helicobacter pylori 1 2 3 4 2 Health conditions associated with stomach acid include gastroesophageal reflux disease (GERD), esophagitis, dyspepsia, chronic gastritis, gastric and duodenal ulcers, andinfection. | 4 | Teterovska Renāte (2025) | Medicinal Plants in Food Supplements for Gastrointestinal Disorders: Critical Assessment of Health Claims on Gastric Acid Regulation |
| Artichoke Leaf Cholesterol Randomized Trial | 5 6 7 8 A potential alternative approach is the use of herbal medicinal products (HMPs) and food supplements (FSs) for the prevention and treatment of diseases and symptoms associated with increased stomach acid. | 4 | Teterovska Renāte (2025) | Medicinal Plants in Food Supplements for Gastrointestinal Disorders: Critical Assessment of Health Claims on Gastric Acid Regulation |
| Artichoke Leaf Cholesterol Randomized Trial | Literature reviews have been conducted on plants found in Asia and their effects on stomach acid, but this type of research has not been conducted on medicinal plants found in Europe [,]. | 4 | Teterovska Renāte (2025) | Medicinal Plants in Food Supplements for Gastrointestinal Disorders: Critical Assessment of Health Claims on Gastric Acid Regulation |
| Artichoke Leaf Cholesterol Randomized Trial | Indigestion or dyspepsia can cause symptoms such as heaviness in the stomach after eating, early satiety and pain or burning in the epigastria, bloating, and nausea. | 4 | Teterovska Renāte (2025) | Medicinal Plants in Food Supplements for Gastrointestinal Disorders: Critical Assessment of Health Claims on Gastric Acid Regulation |
| Artichoke Leaf Cholesterol Randomized Trial | Low-density lipoprotein cholesterol (LDL-C) increases cardiovascular risk, whereas high-density lipoprotein cholesterol (HDL-C) decreases it []. | 4 | Vitulano Nicola (2025) | Effects of Novel Nutraceutical Combination on Lipid Pattern of Subjects with Sub-Optimal Blood Cholesterol Levels |
| Artichoke Leaf Cholesterol Randomized Trial | Clinical evidence supports the effectiveness of lowering LDL-C to prevent cardiovascular events. | 4 | Vitulano Nicola (2025) | Effects of Novel Nutraceutical Combination on Lipid Pattern of Subjects with Sub-Optimal Blood Cholesterol Levels |
| Artichoke Leaf Cholesterol Randomized Trial | Studies show that LDL-C is both a high-risk marker and a direct cause of cardiovascular disease []. | 4 | Vitulano Nicola (2025) | Effects of Novel Nutraceutical Combination on Lipid Pattern of Subjects with Sub-Optimal Blood Cholesterol Levels |
| Artichoke Leaf Cholesterol Randomized Trial | 1 2 3 3 4 3 4 3 5 6 7 Cardiovascular diseases account for 32% of global deaths []. | 4 | Vitulano Nicola (2025) | Effects of Novel Nutraceutical Combination on Lipid Pattern of Subjects with Sub-Optimal Blood Cholesterol Levels |
Source documents